{"id":2303,"date":"2026-04-09T11:00:00","date_gmt":"2026-04-09T02:00:00","guid":{"rendered":"https:\/\/www.lifescience.shokubai.co.jp\/?post_type=news&p=2303"},"modified":"2026-05-08T10:55:30","modified_gmt":"2026-05-08T01:55:30","slug":"nippon-shokubai-to-exhibit-at-tides-usa","status":"publish","type":"news","link":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/2303\/","title":{"rendered":"Nippon Shokubai to Exhibit at TIDES USA"},"content":{"rendered":"\n

NIPPON SHOKUBAI CO., LTD. will exhibit at the TIDES USA.
We look forward to welcoming you.<\/p>\n\n\n\n

<\/div>\n\n\n
\n
\"\"<\/figure>\n<\/div>\n\n\n
<\/div>\n\n\n\n

Exhibition Information<\/strong><\/h3>\n\n\n\n
Exhibition Name<\/td>TIDES USA<\/a><\/td><\/tr>
Date<\/td>May 11-14, 2026<\/td><\/tr>
Venue<\/td>Hynes Convention Center
900 Boylston St, Boston, MA 02115, USA<\/sup>
(Booth No.1006<\/a>)<\/td><\/tr>
Registration<\/td>Advance registration required (paid)
Register here<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
<\/div>\n\n\n\n

Exhibit Categories<\/strong><\/h3>\n\n\n\n

\u30fbContract manufacturing services for mid-molecular APIs (oligonucleotides and peptides)
\u30fbBiocompatible polymers with low immunogenicity, expected for use as DDS materials
\u30fbDrug delivery system (DDS) technologies for selectively delivering mid-molecular therapeutics to target disease sites<\/p>\n\n\n\n

<\/div>\n\n\n\n

Presentation<\/strong><\/h3>\n\n\n\n

A technical presentation will be delivered at a TIDES Talk (short presentation held in the Poster and Exhibit Hall)<\/strong>.<\/p>\n\n\n\n

Date & Time<\/td>May 13, 2026, 10:15 a.m. (Local Time)<\/td><\/tr>
Presenter<\/td>Takaki Habuchi<\/strong>
Research & Development Department, Health & Medical Business Division,
NIPPON SHOKUBAI CO., LTD.<\/td><\/tr>
Title<\/td>A Mild Cleavage and Deprotection Method for RNA Oligonucleotides Synthesized on Universal Supports<\/td><\/tr>
Details<\/td>Nippon Shokubai | TIDES USA: Oligonucleotide & Peptide Therapeutics<\/a><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
<\/div>\n\n\n\n

\u3010Contact us\u3011<\/strong><\/h4>\n\n\n\n

\u3000Health & Medical Business Division
\u3000NIPPON SHOKUBAI CO., LTD.
\u3000URL\uff1ahttps:\/\/www.shokubai.co.jp\/en\/inquiry\/product\/<\/a>
\u3000E-mail\uff1ahealth_medical@shokubai.co.jp<\/a><\/p>\n\n\n\n

<\/p>\n","protected":false},"featured_media":0,"template":"","news_category":[15],"class_list":["post-2303","news","type-news","status-publish","hentry","news_category-event-en"],"acf":{"blank_url":"","pdf_url":null,"select_link":"single_link"},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news\/2303","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/types\/news"}],"version-history":[{"count":9,"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news\/2303\/revisions"}],"predecessor-version":[{"id":2315,"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news\/2303\/revisions\/2315"}],"wp:attachment":[{"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/media?parent=2303"}],"wp:term":[{"taxonomy":"news_category","embeddable":true,"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news_category?post=2303"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}